Clinical Trials Logo

Clinical Trial Summary

Metastatic malignant tumors comprise the vast majority of spinal tumors in adults. The most devastating complication of spinal metastatic disease (SMD) is invasion of the spinal canal and compression of the spinal cord or the nerve roots of the cauda equina, resulting in a clinical entity known as cord compression that manifests with progressive loss of motor function and sensation in the legs, as well as bladder and bowel incontinence.

The treatment of spinal metastases is mostly palliative with the goals of improving or maintaining neurologic function, achieving local tumor control, and spinal stability. Most patients with spinal metastatic disease are currently treated effectively with radiation therapy and/or surgery with good results. There are however certain limitations in the current treatment of SMD. Radiation therapy has two important limitations: 1) if the targeted SMD is in close proximity the spinal cord, delivery of high radiation doses is contraindicated as it may cause radiation-induced damage to the spinal cord (myelopathy, and 2) there is limit on the cumulative amount of radiation dose, which means that recurrent tumors may not be amenable to repeat radiation therapy. As far spinal surgery is concerned, the main limitation is that some patients are not fit for surgery because of medical co-morbidities.

This phase I clinical research trial will test the hypothesis that a new minimally invasive treatment called spinal intra-arterial chemotherapy (SIAC) can be safely applied in patients with SMD.


Clinical Trial Description

To date, there is no effective systemic therapy for spinal metastases, and the goal of treatment is to achieve local control of the tumor. Despite advances in radiation therapy, there is still a subgroup of patients that cannot be effectively treated with radiation because of close proximity of the tumor to the spinal cord. In addition, in cases of recurrent tumors, some patients cannot be re-treated because they reached the maximum allowed radiation dose. Surgery is the alternative treatment for these patients, but some tumors do recur after surgery while some patients have comorbidities that make surgery a high-risk procedure.

Based on our prior experience with selective IA chemotherapy for the treatment of ocular retinoblastoma and the high local control rates achieved with selective IA injection of chemotherapy in recurrent limb melanoma (limb infusion and limb perfusion) we expect that spinal intra-arterial chemotherapy with selective injection of Melphalan in the arteries feeding the metastatic disease is feasible and safe and may prove beneficial in achieving local control of the spinal tumor, preventing neurological compromise from cord compression. This minimally invasive approach can be used in patients in whom radiation therapy and surgery are contra-indicated and essentially have no other treatment options. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01637766
Study type Interventional
Source Weill Medical College of Cornell University
Contact
Status Completed
Phase Phase 1
Start date April 2012
Completion date December 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05484557 - Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury N/A
Not yet recruiting NCT02535273 - The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia Phase 4
Recruiting NCT02187653 - Intraoperative Monitoring (IOM) Patient Registry N/A
Completed NCT00295009 - Safety and Effectiveness Study of Prodisc to Spinal Fusion Surgery N/A
Completed NCT03832036 - The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation N/A
Completed NCT03015142 - Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions
Not yet recruiting NCT06123624 - Desflurane and Sevoflurane on Remifentanil Requirement N/A
Completed NCT03158766 - Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID)
Not yet recruiting NCT02416557 - Effect of PEEP on Intraoperative Hypothermia N/A
Completed NCT02724111 - Effect of Neuromuscular Blockade on Operating Conditions and Overall Satisfaction During Spinal Surgery Phase 4
Enrolling by invitation NCT03492372 - Molecular Characterization of Spinal Tissue
Completed NCT03753945 - Spine MRI in Patients With Deep Brain Stimulation (DBS) N/A
Terminated NCT03802656 - Vertebral Body Tethering Treatment for Idiopathic Scoliosis N/A
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Not yet recruiting NCT02762656 - The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery. Phase 4
Completed NCT00808665 - Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion Phase 4
Completed NCT00756301 - Cutaneous Administration of Local Anesthetic for Spine Injection Procedures N/A
Completed NCT03562455 - Virtual Reality for Power Wheelchair Training N/A
Completed NCT00942227 - The Value of Traction in Treatment of Lumbar Radiculopathy Phase 3
Completed NCT00979108 - The Value of Traction in the Treatment of Cervical Radiculopathy Phase 3